Some Trulieve Cannabis (CNSX:TRUL) Shareholders Are Down 30%

Trulieve Cannabis Corp. (CNSX:TRUL) shareholders should be happy to see the share price up 13% in the last month. But that doesn't change the fact that the returns over the last year have been less than pleasing. The cold reality is that the stock has dropped 30% in one year, under-performing the market.

View our latest analysis for Trulieve Cannabis

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.

Unfortunately Trulieve Cannabis reported an EPS drop of 96% for the last year. This fall in the EPS is significantly worse than the 30% the share price fall. It may have been that the weak EPS was not as bad as some had feared.

The image below shows how EPS has tracked over time.

CNSX:TRUL Past and Future Earnings, October 10th 2019
CNSX:TRUL Past and Future Earnings, October 10th 2019

It's good to see that there was some significant insider buying in the last three months. That's a positive. On the other hand, we think the revenue and earnings trends are much more meaningful measures of the business. Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here..

Advertisement

A Different Perspective

While Trulieve Cannabis shareholders are down 30% for the year, the market itself is up 4.2%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. With the stock down 6.8% over the last three months, the market doesn't seem to believe that the company has solved all its problems. Given the relatively short history of this stock, we'd remain pretty wary until we see some strong business performance. If you want to research this stock further, the data on insider buying is an obvious place to start. You can click here to see who has been buying shares - and the price they paid.

Trulieve Cannabis is not the only stock that insiders are buying. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on CA exchanges.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.

MI
mitchell_lawler
mitchell_lawler

A landmark settlement is meant to punish Meta (META). If the 1998 tobacco deal is any guide, it might protect it.

A landmark settlement is meant to punish Meta (META). If the 1998 tobacco deal is any guide, it might protect it. cover
98
ZO
zoe_vi5fn

Any moat with an opt-out clause for your competitors is just a fence around your own garden.

CO
connor_iwn1g

Worth looking at what previous legal action actually did to Meta rather than reaching for tobacco. The FTC's record five billion dollar privacy fine in 2019 was met with the stock rising, because it came in below fears and removed an open question. GDPR was designed to constrain large platforms and increased their share of the European ad market, because compliance cost fell hardest on small intermediaries. The FTC's antitrust case, the one that could genuinely have broken the company up, was decided in Meta's favour last November. The only thing that ever meaningfully hurt the business was Apple changing a tracking default, and Meta out-spent that too, while the ad-tech firms that could not afford to rebuild disappeared. The pattern is not that Meta survives regulation. It is that regulation keeps costing its smaller competitors more.

Andrew Legget

Great earnings season, but are the earnings real?

Great earnings season, but are the earnings real? cover
At first glance, this was the strongest earnings season in years. But when you look at where the growth actually came from, the story splits into two very different pictures.
10

About CNSX:TRUL

Trulieve Cannabis

Operates as a cannabis retailer in the United States.

Excellent balance sheet and fair value.

Advertisement

Weekly Picks

LO
Lou_Basenese
ONCY logo
Lou_Basenese on Oncolytics Biotech ·

The Team Behind a $2 Billion Johnson & Johnson (JNJ) Deal Just Took Over This $105 Million Cancer Biotech

Fair Value:US$3.575.5% undervalued
23 users have followed this narrative
0 users have commented on this narrative
7 users have liked this narrative
TR
tripledub
Recommended Voice
META logo
tripledub on Meta Platforms ·

The $135 Billion Bet That Should Make Every Shareholder Nervous

Fair Value:US$5861.4% undervalued
59 users have followed this narrative
3 users have commented on this narrative
34 users have liked this narrative
TA
Talos
Emerging Author
VOYG logo
Talos on Voyager Technologies ·

The "Landlord of Orbit" – A Deep Value Play Ahead of the Starlab Era

Fair Value:US$385.291.1% undervalued
60 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
IV
Emerging Author
UBER logo
Ivoed on Uber Technologies ·

Uber’s Valuation Depends On Who Captures The Economics Of Driverless Rides

Fair Value:US$11632.1% undervalued
12 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative

Updated Narratives

AC
INTC logo
achillez_97613 on Intel ·

Fair Value = $110, Bull = $150, Bear = $65.

Fair Value:US$56.0559.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
RE
AGFB logo
RecMag on Agfa-Gevaert ·

Agfa-Gevaert is a digital and materials turnaround opportunity, with growth potential in ZIRFON, but carrying legacy risks.

Fair Value:€5.3991.4% undervalued
28 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
LU
LunaRodas
FRO logo
LunaRodas on Frontline ·

FRO | Frontline: What They Said vs. What They Did

Fair Value:US$34.0729.7% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28022.3% undervalued
365 users have followed this narrative
9 users have commented on this narrative
16 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.9122.3% overvalued
213 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
KI
AMZN logo
KiwiInvest on Amazon.com ·

Amazon's high growth, high tech segments propel its profits, while traditional segments plod along

Fair Value:US$475.0943.9% undervalued
238 users have followed this narrative
1 users have commented on this narrative
8 users have liked this narrative